The legacy of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, yielding billions in revenue , its intellectual property lapse created a wave of knock-off medications, significantly eroding its position . While some pharmaceutical companies may try to capitalize on related tre… Read More